文献速递慢性肾脏病血液净化与透析

CKD进展中的纵向体重变化及其与后续死亡率的关联

Longitudinal Weight Change During CKD Progression and Its Association With Subsequent Mortality.
PubMed 文献 · Am J Kidney Dis · 2017-12-06

在慢性肾脏病(CKD)患者中,体重变化并非线性:当基于胱抑素C的估算肾小球滤过率(eGFRcys)降至<35mL/min/1.73m2后,体重随eGFRcys每下降10mL/min/1.73m2平均减少1.45kg。在开始透析的患者中,eGFR降至<35mL/min/1.73m2后年化体重下降>5%与透析后死亡风险增加54%相关。

要点

  • CKD患者体重在eGFRcys≥35时稳定,低于此阈值后显著下降。
  • eGFRcys<35后年化体重下降>5%与透析后死亡风险增加54%相关。
  • 需研究优化透析前体重和营养状态能否改善终末期肾病结局。

核心结论

  • CKD病程中体重显著下降开始较早,且与透析开始后死亡风险显著升高相关。

研究设计与样本

  • 前瞻性队列研究,纳入CRIC研究3933例CKD患者,并在AASK研究1067例参与者中重复类似分析。

主要发现

  • CRIC中位随访5.7年,体重变化非线性,eGFRcys降至<35mL/min/1.73m2后体重开始下降。
  • eGFRcys每下降10mL/min/1.73m2,体重平均减少1.45kg(95%CI 1.19-1.70)。
  • 770例CRIC参与者开始血透或腹透,eGFR<35后年化体重下降>5%者透析后死亡风险增加54%(95%CI 1.17-2.03)。
  • AASK研究中观察到类似结果。

关键数值与推荐

  • eGFRcys阈值<35mL/min/1.73m2。
  • 年化体重下降>5%定义为显著体重丢失。
  • 体重下降速率:eGFRcys每下降10mL/min/1.73m2,体重减少1.45kg(95%CI 1.19-1.70)。

临床怎么用

  • 对CKD患者,尤其eGFRcys<35mL/min/1.73m2者,应监测体重变化。
  • 透析前出现年化体重下降>5%提示透析后死亡风险增高,需关注营养状态。

局限性

  • 仅纳入研究参与者。
  • 无法区分有意或无意体重下降。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Few studies have investigated the changes in weight that may occur over time among adults with the progression of chronic kidney disease (CKD). Whether such weight changes are independently associated with death after the onset of end-stage renal disease has also not been rigorously examined. STUDY DESIGN: Prospective cohort study. SETTING & PARTICIPANTS: We studied 3,933 participants of the Chronic Renal Insufficiency Cohort (CRIC) Study, a longitudinal cohort of patients with CKD. We also performed similar analyses among 1,067 participants of the African American Study of Kidney Disease and Hypertension (AASK). PREDICTORS: Estimated glomerular filtration rate (eGFR) and weight change during CKD. OUTCOME: Weight and all-cause mortality after dialysis therapy initiation. RESULTS: During a median follow-up of 5.7 years in CRIC, weight change was not linear. Weight was stable until cystatin C-based eGFR (eGFRcys) decreased to <35mL/min/1.73m2; thereafter, weight declined at a mean rate of 1.45 kg (95% CI, 1.19-1.70) for every 10 mL/min/1.73m2 decline in eGFRcys. Among the 770 CRIC participants who began hemodialysis or peritoneal dialysis therapy during follow-up, a >5% annualized weight loss after eGFR decreased to <35mL/min/1.73m2 was associated with a 54% higher risk for death after dialysis therapy initiation (95% CI, 1.17-2.03) compared with those with more stable weight (annualized weight changes within 5% of baseline) in adjusted analysis. Similar findings were observed in the AASK. LIMITATIONS: Inclusion of research participants only; inability to distinguish intentional versus unintentional weight loss. CONCLUSIONS: Significant weight loss began relatively early during the course of CKD and was associated with a substantially higher risk for death after dialysis therapy initiation. Further studies are needed to determine whether interventions to optimize weight and nutritional status before the initiation of dialysis therapy will improve outcomes after end-stage renal disease.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Ku E, Kopple JD, Johansen KL, et al. Longitudinal Weight Change During CKD Progression and Its Association With Subsequent Mortality. Am J Kidney Dis. 2017. PMID: 29217305. doi:10.1053/j.ajkd.2017.09.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。